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Abstract
Background: In the American region, Puerto Rico (PR) has the highest incidence of oral and
pharyngeal cancer (OPC), but racial/ethnic differences have never been assessed and compared
with other groups in the United States of America (USA). We compared the age-adjusted incidence
and mortality rates of OPC between PR and among USA Hispanics (USH), Non-Hispanic Whites
(NHW), and Non-Hispanic Blacks (NHB) to assess the burden of this cancer in PR.
Methods: Analysis of the age-standardized rates (per 100,000) was performed using the direct
method with the world standard population (ASR(World)) from 1998–2002. Annual percent
change (APC) and Relative Risks (RR) were calculated using the Poisson regression model.
Results: The incidence ASR(World) for men in PR was constant (APC ≈ 0.0%), in contrast, a
decrease was observed among NHW, NHB, and USH men, although only USH showed statistical
significance (APC = -4.9%, p < 0.05). In women, the highest increase in incidence (APC = 5.3%) and
the lowest decrease in mortality (APC = -1.4%) was observed in PR. The ratio of the ASR(World)
showed that in all racial/ethnic groups, men had approximately 2–4 fold increased incidence and
mortality risk of OPC than women (p < 0.05). Men in PR had a higher mortality risk (p < 0.05) of
OPC as compared to USH, NHW, and NHB; but among women, PR showed a significant excess
of mortality only as compared to USH (est. SRR = 1.82, 95% CI = 1.41, 2.33).
Conclusion: The overall higher incidence of OPC in men in PR as compared to USH, NHB, and
NHW could be explained by the effect of gene-environment interactions. Meanwhile, the higher
mortality from OPC in PR suggests limitations in the health-care access within this population.
Further research is warranted to elucidate these findings.
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Background
Cancer remains one of the leading causes of morbidity
and mortality worldwide [1], being a major public health
problem in both industrialized and developing countries
[2]. In 2002, an estimated 274,000 cases of oral and pha-
ryngeal cancer (OPC) occurred worldwide, with almost
two-thirds occurring in men [3]. Differences in the pat-
terns of OPC occurrence worldwide reflect variations in
the prevalence of specific risk factors within the regions
with the highest incidence rates, such as tobacco and alco-
hol consumption in Western Europe, chewing of betel
quid in South-Central Asia and Melanesia, and solar irra-
diation in the South Pacific [4,5].
In the American region, the age-standardized incidence
rate (World) of OPC in 2002 showed different patterns of
disease occurrence by sex and among countries. Overall,
men showed higher incidence rates than women [5]. In
South and North America, the highest incidences among
men were observed in Brazil (8.3 per 100,000 men) and
the United States of America (USA) (7.9 per 100,000
men), respectively [5]. In the Caribbean, Puerto Rican
men showed the highest incidence (10.6 per 100,000
men) followed by Cuba (6.4 per 100,000 men) [5]. None-
theless, the incidence of OPC in women in Puerto Rico
(PR) was lower (2.5 per 100,000 women) when compared
with other Western Hemisphere countries, such as the
USA (3.4 per 100,000 women) and Cuba (2.8 per
100,000 women) [5].
Racial and ethnic differences in OPC incidence and mor-
tality rates in the USA have been documented among USA
Hispanics (USH), Non Hispanic Whites (NHW), and Non
Hispanic Blacks (NHB), but not extensively characterized
for Puerto Ricans living in PR [6,7]. Ethnic variations in
the burden of OPC in the USA may be explained by differ-
ences in cultural and regional characteristics, health-
related habits, or genetic constitution among these groups
[8]. Other factors that perhaps contribute to this phenom-
enon include differences in access to screening and access
to timely state-of-the-art treatments [9].
Studying the burden of OPC in PR is of special relevance
as this is the fifth most frequent cancer type among men
and the sixth most common cause of mortality in this
group [10]. Although a previous study compared OPC
mortality among Puerto Ricans and NHW in the USA for
the 1973–1977 period [11], this study did not compare
the Puerto Rican population with other racial/ethnics
groups in the USA, such as USH and NHB. The compari-
son of PR's cancer statistics with that of other racial/ethnic
groups in the USA is of interest, given the political and
sociocultural relationships of PR with the USA [12], and
given that the Puerto Rican population (similar to other
Hispanic subgroups) [13] resulted from the admixing of
the genomes of Spaniards (Europeans), Africans, and
Taínos (Caribbean natives) [14]. Thus, a comparison of
OPC incidence and mortality rates in PR with that of other
racial/ethnic groups in the USA is not only necessary to
understand differences and similarities in the occurrence
of this cancer across these populations, but as suggested in
the field of genetic epidemiology [15,16] it could also pro-
vide relevant information on the influence of genetic and
environmental factors on disease occurrence. As a conse-
quence, the main aim of our study was to assess the age-
standardized incidence and mortality rates of OPC in PR
as compared to USH, NHW, and NHB for the period of
1998–2002.
Methods
Data sources
Data sources for this analysis included the SEER program
and the PRCCR. The SEER program is a cancer surveillance
database that collects and reports incidence data from a
sample of the USA population. The PRCCR has collected
information on cancer in PR since 1951, being one of the
oldest population-based cancer registries in the American
Continent; The PRCCR is part of the National Program of
Cancer Registries (NPCR) administered by the Centers of
Disease Control and Prevention (CDC). The PRCCR uses
the coding standards of the SEER and of the North Amer-
ican Association of Central Cancer Registries (NAACCR);
thus the registry is fully comparable with SEER data. In the
year 2003, a CDC audit concluded that 95.3% of all can-
cer cases diagnosed or treated in hospital facilities in
Puerto Rico were appropriately reported to the PRCCR; a
result comparable to the US median (95%) [17].
The third revision of the International Classification of
Diseases for Oncology (ICD-O-3) was used to select all
cases diagnosed from OPC from 2001 and later (site codes
C000–C148) for this analysis [18]. Cases from 1998 to
2000, which were originally reported using ICD-O-2, were
converted to ICD-O-3. OPC incidence statistics from 1998
to 2002 for PR were obtained from the PRCCR. Incident
cases for the same time period for NHW, NHB, and USH
in the USA were obtained with the SEER*Stat 6.3.5 soft-
ware (National Cancer Institute Surveillance Program,
Bethesda, MD) and based on SEER 13. The SEER program
identifies Hispanic ethnicity by a combination of medical
record review and matching surnames against a list of His-
panic surnames. The term Hispanic used throughout this
study does not account racial differences within the US
Hispanic population.
The International Classification of Diseases, Tenth Revi-
sion (ICD-10) was used to select deaths of OPC for this
analysis from 1999 and later (C00–C14) [19]. OPC
deaths from 1998 were coded using ICD-9 (site codes
140–149). For PR, mortality information was obtainedBMC Cancer 2009, 9:129 http://www.biomedcentral.com/1471-2407/9/129
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from the PRCCR as reported by death certificates enacted
by the Puerto Rico Health Department. For the USA, OPC
mortality information was obtained from the SEER pro-
gram as reported by the National Center for Health Statis-
tics (NCHS). USA mortality cases were obtained for all
states except Connecticut, Maine, Maryland, Minnesota,
New Hampshire, New York, North Dakota, Oklahoma,
and Vermont because of the large number of individuals
with unknown origin or ethnicity for several years. The
"Hispanics Index" as developed by the National Cancer
Institute was used to exclude these states, where mortality
statistics for Hispanics were deemed unreliable.
Statistical Analysis
For each racial/ethnic group, we applied the direct
method to compute OPC age-standardized incidence and
mortality rates (per 100,000 persons) during 1998 to
2002, using the World Standard Population [20]. These
rates were identified by ASR(World), either for incidence
and mortality, and were computed annually in a period of
five years. To assess the trend of OPC risk during 1998
until 2002, the annual ASR(World) were calculated by
sex, as follows:   where wj is the
proportion of persons in the j-th age group of the standard
population (World Population), dk
ij is the number of
cases (new cases or deaths) in the j-th age group for the i-
th ethnic group in the k-th year, and nk
ij is the population
in the j-th age group of the i-th ethnic group in the k-th
year. The annual percent change (APC) of the ASR(World)
was estimated, overall and by sex, using the joinpoint
regression model [21]. The Joinpoint Regression Program
[22] was used for the APC estimation with the following
parameters: 1) log transformation of the rate, 2) zero join-
point model, 3) Poisson model using rate, 4) uncorrelated
error model, and 5) Hudson's method.
To assess racial/ethnic group's differences, the ASRs
(World) were grouped during the study period, as follows:
. Then, the ratio of two
standardized rates
 between two
different groups were estimated with 95% confidence
intervals [23], to assess significant differences in OPC inci-
dence and mortality rates between PR as compared to
USH, NHB, and NHW. This ratio was denoted as Stand-
ardized Rate Ratio (SRR).
In addition, specific incidence and mortality rates for dif-
ferent age groups were computed during 1998–2002, by
sex. Based on these rates, the relative risks (RR) were esti-
mated with 95% confidence intervals to determine rela-
tive differences among the study groups by sex and five-
year age groups using the Poisson regression model [24].
The reference racial/ethnic group in the age-specific RR
estimation was PR. The statistical analysis was performed
with the statistical package STATA 10.
Results
Trends of ASR (World)
The annual ASR (World) for incidence of OPC during the
study period (1998–2002) showed different patterns
among the racial/ethnic groups studied (Figure 1). Men in
PR showed a constant pattern for incidence from 1998 to
2002 (APC ≈ 0.0%), in contrast, a decrease was observed
among NHW, NHB, and USH; although it was statistically
significant only among USH (APC = -4.9%, p < 0.05). For
mortality rates, declining trends were also observed for
USH, NHW, and NHB men; although an increasing trend
was observed among men in PR (APC = 1.2%). Among
women, increasing incidence patterns were observed
among PR (APC = 5.3%), NHB (APC = 3.0%), and USH
(APC = 3.2%), but not for NHW (APC = -0.2). Meanwhile,
although women in PR (APC = -1.4%) and in all other
racial/ethnic groups showed declining mortality trends,
this trend was only significant among NHB women (APC
= -5.4%, p < 0.05).
ASR (World)
The ASR(World) for 1998–2002 showed that in all racial/
ethnic groups, men had approximately 2–4 fold increased
incidence and mortality risk of OPC than women (p <
0.05). For example, men in PR were associated with 3.6-
fold increased incidence (95%CI: 3.1, 4.1) and 3.5-fold
increased mortality (95% CI = 2.78, 4.47) when com-
pared to women. For the sex comparison in the other
racial/ethnic groups, these fold increased risks were simi-
lar with those of NHB (Table 1). Among men, the ratio of
the ASR(World) for incidence of OPC showed that PR had
1.96-fold increased risk (95%CI: 1.69, 2.29) compared to
USH and 1.14 fold increased risk (95%CI: 1.05, 1.22)
compared to NHW; no significant difference (p > 0.05)
was seen between PR and NHB. For mortality, PR had a
1.15–2.27 fold increased risk (p < 0.05) from OPC com-
pared to USH, NHW, and NHB. Among women, no sig-
nificant differences (p > 0.05) in incidence rates were
observed between PR and USH and NHB, although
women in PR showed a 36% (est. SRR = 0.74, 95% CI =
0.65, 0.83) lower risk when compared to NHW. Mean-
while, women in PR showed a significant excess (p < 0.05)
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of mortality of OPC as compared to USH (est. SRR = 1.82,
95% CI = 1.41, 2.33), although no differences were
observed between PR and NHW or NHB (P > 0.05).
Relative Risks
When the incidence and mortality of OPC in PR were
compared with the other racial/ethnic groups for each
specific sex and age-group, various patterns were observed
during the period 1998–2002 (Figure 2). When compared
to Puerto Rican men, their NHW, NHB, and USH counter-
parts in the continental USA had lower incidence in the
age group = 80 years old (p < 0.05). In all other age
groups, USH also had a lower incidence when compared
with PR; whereas, NHB men showed higher incidence in
the age groups 40–49, 50–59, and 60–69 (p < 0.05).
Meanwhile, USH and NHW men showed lower mortality
than men in PR in all age groups (p < 0.05); whereas, NHB
had a significant higher risk of death (p < 0.05) at the age
of 60–69 as compared to PR. Among women, NWH and
NHB had a higher incidence (p < 0.05) of OPC when
compared to women in PR, in the age groups 40–49, 50–
59, and 60–69; whereas no age-group specific differences
were seen between PR and USH (p > 0.05). Regarding
mortality, only NHB women between 40 to 69 years of
age had increased risk of death from OPC as compared to
PR (p < 0.05); whereas, NHW and USH women had sim-
ilar mortality in these age-groups.
Discussion
During the study period, 1998–2002, the ASR(World) of
OPC incidence and mortality were higher in men in PR
than among USH, NHB, and NHW men. This higher bur-
den of OPC in PR is consistent with studies performed in
the 60's and 70's comparing cancer risk in PR and the USA
Annual ASR (World) for oral and pharyngeal cancer incidence and mortality, 1998–2002 Figure 1
Annual ASR (World) for oral and pharyngeal cancer incidence and mortality, 1998–2002.
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[12,25]. Moreover, our study adds the comparison of
these rates with two additional racial/ethnic groups (USH
and NHB). Contrary to declining incidence and mortality
trends observed for men in the other racial/ethnic groups,
men in PR had a constant trend for incidence and increas-
ing mortality trends. Although women in PR had lower
incidence rates of OPC than NHB and NHW women, they
had the highest increase for incidence and the lowest
decrease for mortality when compared to the other three
racial/ethnic groups. These results highlight a health dis-
parity for PR that warrants further investigation.
The observed high burden of OPC in PR and increasing
patterns of disease occurrence in this population are
potentially the result of multiple factors, including life-
style factors, genetics, acculturation, and screening prac-
tices within this population. Tobacco smoking explains
some of the sex and racial differences in OPC risk [26]. A
large case-control study of OPC in the USA showed that
variation in the prevalence of use and the risks associated
with tobacco and alcohol accounts for much of the higher
incidence among men than women and among NHB as
compared to NHW. [27]. In PR, it has been estimated that
the attributable risk of OPC due to alcohol and tobacco
use is around 76% (95%CI = 65–87%) for men and 52%
(95%CI: 28–75%) for women [28]. Similar attributable
risks have been reported in the USA [29].
Another study in PR also showed that OPC cancer in PR is
strongly associated to liquor consumed straight, suggest-
ing that alcohol concentration is a risk factor for OPC,
independent of the total quantity of alcohol consumed
[30]. In addition, risks associated with combined expo-
sure to tobacco were also more pronounced when subjects
drank liquor straight. In PR, straight liquor intake is
reported more commonly among men (41%) than in
their NHW counterparts in the USA (18%) [31]. Further-
more, locally produced, homemade rum is commonly
consumed in PR and has been suspected to contain poten-
tially carcinogenic contaminants [32]. Nevertheless, a
study suggests that the risks associated with drinking
homemade rum in this population are similar to those of
other types of liquor [30].
Another factor that may explain the excess of OPC risk is
the use of tobacco products. According to the Behavioral
Risk factor Surveillance System (BRFSS), 14.5% of the
adult population in PR reported cigarette smoking in
1996 and just 12.2% in 2007 [33]. Smaller studies con-
ducted in PR prior to 1996 (1982 and 1989) suggest a
declining trend in cigarette consumption. The prevalence
of smoking has also consistently declined for the last three
decades for NHW, USB, and USH [33,34]. Even with the
declines reported for all the studied groups, PR has had a
historically lower prevalence, almost one third, of ciga-
rette smoking than NHW, NHB, and USH, which does not
support the higher burden of OPC in our population.
Nonetheless, this needs to be interpreted with caution as
a delay of several decades is usually apparent between the
first time of exposure to tobacco and the development of
oral malignances [35]. In addition, given that historical
data on tobacco consumption in PR is scarce, its difficult
to correlate tobacco use and OPC risk in this population
through the use of ecologic measures [36].
Genetic predispositions in PR should also be considered,
as these predispose to the development of OPC at an early
age [37]. In a population-based case-control study con-
ducted in PR, the null GSTM1 genotype was associated
with a marginally significant decrease in oral cancer risk
(est. OR = 0.6, 95%CI: 0.3–1.0) [38]. The same study con-
cluded that oral cancer risk augmented with increasing
cigarette use among subjects with the GSTT1-present gen-
otype (est. OR = 9.5, 95%CI: 3.0–30, among the heaviest
Table 1: ASR(World) for incidence and mortality (per 100,000) for oral and pharyngeal cancer during 1998–2002.
Age Standardized Rate (ASR) Standardized Relative Ratioa (SRR)
PR USH NHW NHB PR vs. USHb PR vs. NHWb PR vs. NHBb
Incidencec
Male 18.5 9.5 16.3 17.3 1.96 (1.69, 2.22) 1.14 (1.05, 1.22) 1.08 (0.96, 1.19)
Female 5.2 4.3 7.1 5.4 1.20 (1.00, 1.45) 0.74 (0.65, 0.83) 0.95 (0.81, 1.12)
SRR Men vs. 
Womenb
3.56 (3.10, 4.12) 2.20 (1.83, 2.65) 2.30 (2.21, 2.41) 3.17 (2.79, 3.45)
Mortalityc
Male 7.9 3.5 4.4 6.8 2.27 (1.92, 2.70) 1.79 (1.59, 2.00) 1.15 (1.01, 1.30)
Female 2.3 1.2 2 2.1 1.82 (1.41, 2.33) 1.10 (0.88, 1.35) 1.09 (0.86, 1.33)
SRR Men vs. 
Womenb
3.50 (2.78, 4.47) 2.80 (2.36, 3.35) 2.17 (2.10, 2.23) 3.29 (3.03, 3.46)
a The ratio of two ASR (World) with 95% confidence interval between parentheses.
b Reference group
c ×100,000BMC Cancer 2009, 9:129 http://www.biomedcentral.com/1471-2407/9/129
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cigarette users). Thus, further studies are warranted to
determine if the frequency of these genetic polymor-
phisms, among other well known oncogenes, in PR is
higher than among USH, NHW, or NHB; or if gene envi-
ronment interactions vary among these groups.
Some attention also should be drawn to other lifestyle,
immunologic, and environmental potential risk factors
for OPC in PR, as these could be influencing the increased
burden of OPC in this population. Relevant risk factors
for OPC include mouthwash use [39], poor oral hygiene
and poor dentition [40], oral cavity infections and dis-
eases, denture sores, oral mucosal lesions [41], and sun-
light exposure [42]. Also, exposure to sexually transmitted
infections, such as the human papilloma viruses (HPV)
[43], herpes viruses [37], and human immunodeficiency
virus (HIV) [44] could impact OPC risk. Although no
population-based data on the prevalence of HPV or her-
pes viruses has been published for PR that might explain
the observed patterns of OPC occurrence, a higher inci-
dence of HPV has been observed in developing countries
of Latin America (33.5 per 100,000) and the Caribbean
(33.5) [45] as compared to North America (< 15 per
100,000). Meanwhile, PR ranks fifth among all USA's
states and territories in the rate of reported AIDS cases
(26.4 per 100,000) [46]. Thus, a potentially high burden
of these infections agents could be influencing the burden
of OPC in PR, although additional population-based data
is warranted.
Relative Risks' (95% CI) for incidence and mortality of oral and pharyngeal cancer in the Non-Hispanic Whites (NHW), Non- Hispanic Blacks (NHB), and the USA Hispanics (USH) when compared to Puerto Rico, 1998–2002 Figure 2
Relative Risks' (95% CI) for incidence and mortality of oral and pharyngeal cancer in the Non-Hispanic Whites 
(NHW), Non-Hispanic Blacks (NHB), and the USA Hispanics (USH) when compared to Puerto Rico, 1998–
2002.
BMC Cancer 2009, 9:129 http://www.biomedcentral.com/1471-2407/9/129
Page 7 of 9
(page number not for citation purposes)
In addition, dietary insufficiencies, specially fruit and veg-
etables, and low levels of serum nutrients such as caroten-
oids [47] could play a role in the observed results. Several
studies have indicated a protective role for OPC of fruits
and vegetables, although the specific agent is uncertain.
For example, folates (found in a variety of foods, particu-
larly green leafy vegetables, grain products, and orange
juice) have long been hypothesized to be related to cancer
risk [48]. A study conducted in PR showed that folate
intake from fruit decreased OPC risk (p = 0.001) but other
dietary folate sources showed no clear association (p >
0.05). In PR, fruit and vegetable consumption (5 or more
per day) has decreased in the last decade (1996–2007)
from 20.3% to 13.7%; meanwhile, the consumption for
the USH, NHW, and NHB population has not showed a
decrease and remains higher than that in PR [33]. This low
consumption of fruit and vegetables as a direct source of
folate may help to explain the higher incidence of OPC in
PR. Nonetheless, historic nutritional information for PR is
scare, limiting our ability to further explain the observed
trends. Future studies should elucidate the role of diet on
OPC risk PR.
The annual ASR (World) for mortality of OPC showed a
decline in all racial/ethnic groups, except for men in PR.
These declines could be explained by the participation in
early detection programs, particularly of women [49-51].
This disparity for Puerto Rican men suggests that access to
advances in treatment, screening, and early detection are
not optimum in this population. In fact, a recent study by
Morse found disparities in the detection of very early oral
cancer in PR as compared with the USA [7]. Studies in this
area are necessary to elucidate this argument. In addition,
efforts must be made to increase the prevalence of OPC
screening in PR, as early detection of OPC lesions is the
most important factor in the prognosis and cure of this
cancer.
Due to the acculturation process, it has been suggested
that Hispanic migrants have cancer rates similar to NHW
[3,8]. However, our results showed that USH men and
women have lower incidence of OPC than NHW but a
very similar mortality, a fact that has been explained by
several factors, such as differences in health practices and
health care access [3,8]. Among the Hispanic community
living in the continental USA, acculturation occurs more
markedly when they arrive to this country. Meanwhile, in
the Hispanic population living in PR, acculturation has
occurred through the close sociopolitical relationship
with the USA since 1898 [12]. Given that the population
of PR has experienced an acculturation process different
from that of USH, the comparison of OPC incidence and
mortality between these groups and the NHW and NHB
populations is essential for further understanding differ-
ences and similarities of disease occurrence between these
groups, that permit the identification of health disparities.
However, because of the differences in the populations
included under the broad heading of "United States His-
panics" [52] we cannot conclude that acculturation alone
can explain the differences observed among Puerto Ricans
and USH.
Conclusion
In conclusion, our study shows an overall higher inci-
dence of OPC in men in PR as compared to USH, NHB,
and NHW. This result could be explained by the effect of
gene-environment interactions. Meanwhile, the higher
mortality from OPC in PR suggests limitations in the
health-care access within this population. Further research
is warranted to elucidate these findings. A comparison of
OPC incidence and mortality between the population
residing in PR and the Puerto Rican immigrants living in
the continental USA would permit a more appropriate
comparison that minimizes genetic differences, and con-
tributes to the better identification of social, lifestyle, envi-
ronmental, and biologic risk factors associated to disease
occurrence and death in the Puerto Rican population.
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